Tag:
Juvisync
Latest Headlines
Latest Headlines
Merck augments Januvia franchise with statin combo
Merck ( $MRK ) just extended its Januvia franchise with the FDA approval of Juvisync, a combination pill comprised of the company's diabetes drug and its now-off-patent cholesterdol pill Zocor
Merck wins FDA nod for new combo drug for diabetes and high cholesterol
As Merck ( $MRK ) works on building up its ever-important diabetes business, U.S. regulators have stamped an approval on the drug giant's combo therapy for patients with type 2 diabetes who also have
